The influence of tamoxifen on normal mouse mammary gland homeostasis

Breast Cancer Research

Volumn 16, Issue 4, 2014, Pages

  Shehata, Mona ^a   van Amerongen, Renée ^b   Zeeman, Amber L ^b   Giraddi, Rajshekhar R ^a   Stingl, John ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 INTEGRIN; CASPASE 3; EPITHELIAL CELL ADHESION MOLECULE; TAMOXIFEN;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BASAL CELL; BODY WEIGHT; BREAST EPITHELIUM; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FLOW CYTOMETRY; GROWTH INHIBITION; HOMEOSTASIS; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MAMMARY GLAND; MOUSE; NONHUMAN; PUBERTY; STEM CELL; ANIMAL; DRUG EFFECTS; EPITHELIUM CELL; METABOLISM; PHYSIOLOGY; SEXUAL MATURATION; UDDER;

ANIMALS; CELL PROLIFERATION; EPITHELIAL CELLS; FEMALE; HOMEOSTASIS; MAMMARY GLANDS, ANIMAL; MICE; SEXUAL MATURATION; TAMOXIFEN;

EID: 84905816436     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/s13058-014-0411-0     Document Type: Article

References (33)

1. Blanpain C, Simons BD. Unravelling stem cell dynamics by lineage tracing. Nat Rev Mol Cell Biol 2013, 14:489-502. 10.1038/nrm3625, 23860235.
2. Van Keymeulen A, Rocha AS, Ousset M, Beck B, Bouvencourt G, Rock J, Sharma N, Dekoninck S, Blanpain C. Distinct stem cells contribute to mammary gland development and maintenance. Nature 2011, 479:189-193. 10.1038/nature10573, 21983963.
3. de Visser KE, Ciampricotti M, Michalak EM, Tan DW, Speksnijder EN, Hau CS, Clevers H, Barker N, Jonkers J. Developmental stage-specific contribution of LGR5(+) cells to basal and luminal epithelial lineages in the postnatal mammary gland. J Pathol 2012, 228:300-309. 10.1002/path.4096, 22926799.
4. van Amerongen R, Bowman AN, Nusse R. Developmental stage and time dictate the fate of Wnt/beta-catenin-responsive stem cells in the mammary gland. Cell Stem Cell 2012, 11:387-400. 10.1016/j.stem.2012.05.023, 22863533.
5. Feil R, Brocard J, Mascrez B, LeMeur M, Metzger D, Chambon P. Ligand-activated site-specific recombination in mice. Proc Natl Acad Sci U S A 1996, 93:10887-10890. 10.1073/pnas.93.20.10887, 8855277.
6. Feil R, Wagner J, Metzger D, Chambon P. Regulation of Cre recombinase activity by mutated estrogen receptor ligand-binding domains. Biochem Biophys Res Commun 1997, 237:752-757. 10.1006/bbrc.1997.7124, 9299439.
7. Indra AK, Warot X, Brocard J, Bornert JM, Xiao JH, Chambon P, Metzger D. Temporally controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombinases. Nucleic Acids Res 1999, 27:4324-4327. 10.1093/nar/27.22.4324, 10536138.
8. Huh WJ, Khurana SS, Geahlen JH, Kohli K, Waller RA, Mills JC. Tamoxifen induces rapid, reversible atrophy, and metaplasia in mouse stomach. Gastroenterology 2012, 142:21-24. e27, 10.1053/j.gastro.2011.09.050, 22001866.
9. Zhu Y, Huang YF, Kek C, Bulavin DV. Apoptosis differently affects lineage tracing of Lgr5 and Bmi1 intestinal stem cell populations. Cell Stem Cell 2013, 12:298-303. 10.1016/j.stem.2013.01.003, 23415913.
10. Mouridsen H, Palshof T, Patterson J, Battersby L. Tamoxifen in advanced breast cancer. Cancer Treat Rev 1978, 5:131-141. 10.1016/S0305-7372(78)80017-6, 365330.
11. Shehata M, Teschendorff A, Sharp G, Novcic N, Russell A, Avril S, Prater M, Eirew P, Caldas C, Watson CJ, Stingl J. Phenotypic and functional characterization of the luminal cell hierarchy of the mammary gland. Breast Cancer Res 2012, 14:R134. 10.1186/bcr3334, 23088371.
12. Nelson JF, Felicio LS, Randall PK, Sims C, Finch CE. A longitudinal study of estrous cyclicity in aging C57BL/6 J mice: I. Cycle frequency, length and vaginal cytology. Biol Reprod 1982, 27:327-339. 10.1095/biolreprod27.2.327, 6889895.
13. Byers SL, Wiles MV, Dunn SL, Taft RA. Mouse estrous cycle identification tool and images. PLoS One 2012, 7:e35538. 10.1371/journal.pone.0035538, 22514749.
14. Young LJT. The Cleared Mammary Fat Pad and the Transplantation of Mammary Gland Morphological Structures and Cells 2000, Kluwer Academic/Plenum Press, New York, US.
15. Hu Y, Smyth GK. ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J Immunol Methods 2009, 347:70-78. http://bioinf.wehi.edu.au/software/elda/, 10.1016/j.jim.2009.06.008, 19567251.
16. Prater M, Shehata M, Watson CJ, Stingl J. Enzymatic dissociation, flow cytometric analysis, and culture of normal mouse mammary tissue. Methods Mol Biol 2013, 946:395-409. 10.1007/978-1-62703-128-8_25, 23179846.
17. Hovey RC, Asai-Sato M, Warri A, Terry-Koroma B, Colyn N, Ginsburg E, Vonderhaar BK. Effects of neonatal exposure to diethylstilbestrol, tamoxifen, and toremifene on the BALB/c mouse mammary gland. Biol Reprod 2005, 72:423-435. 10.1095/biolreprod.104.029769, 15470002.
18. Kotoula V, Karkavelas G, Economou L, Sionga A, Boutis L, Kerameos-Foroglou C. Effects of tamoxifen and CV 205502 on the morphology and the evolution of the noncancerous mouse mammary gland. Histol Histopathol 1993, 8:627-636. 7905759.
19. Haslam SZ, Nummy KA. The ontogeny and cellular distribution of estrogen receptors in normal mouse mammary gland. J Steroid Biochem Mol Biol 1992, 42:589-595. 1637722.
20. Barker N, van Oudenaarden A, Clevers H. Identifying the stem cell of the intestinal crypt: strategies and pitfalls. Cell Stem Cell 2012, 11:452-460. 10.1016/j.stem.2012.09.009, 23040474.
21. Alcolea MP, Jones PH. Tracking cells in their native habitat: lineage tracing in epithelial neoplasia. Nat Rev Cancer 2013, 13:161-171. 10.1038/nrc3460, 23388619.
22. Sherman BM, Chapler FK, Crickard K, Wycoff D. Endocrine consequences of continuous antiestrogen therapy with tamoxifen in premenopausal women. J Clin Invest 1979, 64:398-404. 10.1172/JCI109475, 110834.
23. Jordan VC, Fritz NF, Langan-Fahey S, Thompson M, Tormey DC. Alteration of endocrine parameters in premenopausal women with breast cancer during long-term adjuvant therapy with tamoxifen as the single agent. J Natl Cancer Inst 1991, 83:1488-1491. 10.1093/jnci/83.20.1488, 1920495.
24. Groom GV, Griffiths K. Effect of the anti-oestrogen tamoxifen on plasma levels of luteinizing hormone, follicle-stimulating hormone, prolactin, oestradiol and progesterone in normal pre-menopausal women. J Endocrinol 1976, 70:421-428. 10.1677/joe.0.0700421, 978103.
25. Rios AC, Fu NY, Lindeman GJ, Visvader JE. In situ identification of bipotent stem cells in the mammary gland. Nature 2014, 506:322-327. 10.1038/nature12948, 24463516.
26. Osborne CK, Boldt DH, Clark GM, Trent JM. Effects of tamoxifen on human breast cancer cell cycle kinetics: accumulation of cells in early G1 phase. Cancer Res 1983, 43:3583-3585. 6861130.
27. Taylor IW, Hodson PJ, Green MD, Sutherland RL. Effects of tamoxifen on cell cycle progression of synchronous MCF-7 human mammary carcinoma cells. Cancer Res 1983, 43:4007-4010. 6871842.
28. Robinson SP, Langan-Fahey SM, Johnson DA, Jordan VC. Metabolites, pharmacodynamics, and pharmacokinetics of tamoxifen in rats and mice compared to the breast cancer patient. Drug Metab Dispos 1991, 19:36-43. 1673419.
29. Fong CJ, Burgoon LD, Williams KJ, Forgacs AL, Zacharewski TR. Comparative temporal and dose-dependent morphological and transcriptional uterine effects elicited by tamoxifen and ethynylestradiol in immature, ovariectomized mice. BMC Genomics 2007, 8:151. 10.1186/1471-2164-8-151, 17555576.
30. Williams C, Edvardsson K, Lewandowski SA, Strom A, Gustafsson JA. A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells. Oncogene 2008, 27:1019-1032. 10.1038/sj.onc.1210712, 17700529.
31. Mandlekar S, Kong AN. Mechanisms of tamoxifen-induced apoptosis. Apoptosis 2001, 6:469-477. 10.1023/A:1012437607881, 11595837.
32. Mandlekar S, Yu R, Tan TH, Kong AN. Activation of caspase-3 and c-Jun NH2-terminal kinase-1 signaling pathways in tamoxifen-induced apoptosis of human breast cancer cells. Cancer Res 2000, 60:5995-6000. 11085519.
33. Beleut M, Rajaram RD, Caikovski M, Ayyanan A, Germano D, Choi Y, Schneider P, Brisken C. Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland. Proc Natl Acad Sci U S A 2010, 107:2989-2994. 10.1073/pnas.0915148107, 20133621.